BackRevelation Biosciences- Warrants(10/01/2027) Overview

Revelation Biosciences- Warrants(10/01/2027) Long Term Debt

Latest long-term debt for REVBW: $550K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$550546.00

Peer average / median

Loading

Revelation Biosciences- Warrants(10/01/2027) Long Term Debt History

Loading

Revelation Biosciences- Warrants(10/01/2027) vs. peers: Long Term Debt Comparison

Loading

Revelation Biosciences- Warrants(10/01/2027) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Revelation Biosciences- Warrants(10/01/2027) (REVBW) FAQ

Revelation Biosciences- Warrants(10/01/2027) (REVBW) currently reports a long-term debt of $550K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Revelation Biosciences- Warrants(10/01/2027)'s long-term debt history and peer comparisons.

Revelation Biosciences- Warrants(10/01/2027)'s long-term debt changed from $0 to $550K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Revelation Biosciences- Warrants(10/01/2027) reported $550K in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $550K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Revelation Biosciences- Warrants(10/01/2027), and consider following REVBW for alerts when major investors trade the stock.